Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement

CONTEXT: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundra, Tanveer Singh, Nagaraja, P S, Bharathi, K S, Kaur, Parminder, Manjunatha, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article: Janak Mehta Award
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078018/
https://www.ncbi.nlm.nih.gov/pubmed/30052230
http://dx.doi.org/10.4103/aca.ACA_19_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078018/
https://www.ncbi.nlm.nih.gov/pubmed/30052230
http://dx.doi.org/10.4103/aca.ACA_19_18

Ejemplares similares